It was only a matter of time until the GLP-1 receptor agonist drugs like Ozempic and Wegovy were superseded, and now it looks ...
The trial results are critical, as it brings Eli Lilly's pill one step closer to becoming a new, needle-free alternative for ...
A new study has found that a once-weekly injection of semaglutide, a medication originally developed for diabetes and weight ...
Eli Lilly launched its weight loss drug Mounjaro in India. According to the company, the injection is supposed to be taken ...
US pharmaceutical company Eli Lilly has launched Mounjaro, a diabetes and weight-loss drug, in India. Priced at Rs 3,500 for a 2.5 mg vial, the ‘game-changing’ medication has debuted in the Indian ...
Popular anti-diabetes and obesity drug Mounjaro, containing the active ingredient tirzepatide, is now available in India in a ...
CT-388 also is a once-a-week injection that's in Phase 2 trials ... (NVO), which along with Eli Lilly (LLY) dominates the weight-loss category, slumped 4%, though the company also has been under ...